Dopo l'orario di chiusura: 117.99

Rogers Corp. (ROG)

Rogers Corp. Borsa (ROG) Ultime notizie

Rogers Corp. (ROG)

Rogers Corp. Borsa (ROG) Ultime notizie

Jump Financial LLC Invests $1.26 Million in Rogers Co. (NYSE:ROG) - Defense World

Rogers Corp. (ROG) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Lifestyle UK

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports positive Phase I results for its dual GLP-1/GIP receptor agonist CT-388 in people with obesity

Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer

Rogers Corporation to Participate in Upcoming Investor Conferences - Business Wire

Rogers Corp. (ROG) Surpasses Q2 Earnings Estimates - Yahoo Lifestyle UK

DuPont scraps $5.2 billion Rogers buyout due to China hurdles - Yahoo Movies UK

Rogers Corp. (ROG) Tops Q1 Earnings and Revenue Estimates

Rogers Corp.: Q1 Earnings Snapshot - Quartz

Rogers Corporation Reports First Quarter 2024 Results - Business Wire

Rogers Corp. (ROG) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

Can These 5 Electronics Stocks Hit Targets This Earnings Season?

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19

Rogers Corporation: Short-Term Headwinds Are Likely Temporary (NYSE:ROG) - Seeking Alpha

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study

Rogers Schedules First Quarter 2024 Earnings Call for April 25 - Yahoo Finance

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

Roche receives FDA approval for the first molecular test to screen for malaria in blood donors

Are Rogers Corporation's (NYSE:ROG) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Simply Wall St

Can Mnuchin Save NYCB From Itself?

Is SPDR MSCI EAFE StrategicFactors ETF (QEFA) a Strong ETF Right Now?

Roche Annual General Meeting 2024

Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care

Technical Analysis of Rogers Corp. — TradingView News - TradingView

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Rogers Corp (ROG) Faces Headwinds: Q4 and Full Year 2023 Earnings Analysis - Yahoo Finance

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Rogers Corporation Announces New Factory in Monterrey, Mexico - Business Wire

Rogers Corporation Reports Fourth Quarter and Full Year 2023 Results - Yahoo Finance

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Rogers urges CRTC to prioritize costs of companies that build internet networks - The Globe and Mail

Rogers shuffles executive team after head of residential operations exits - The Globe and Mail

This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk

This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk

This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk

First look exclusive: Rogerscorp set for Gold Coast townhouse development - Urban

New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)

[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline

Former Rogers company owner, former CEO sentenced to prison time and $8 million in damages - KNWA

Rogers medical supply company owner, former CEO sentenced to prison for billing fraud | Arkansas Democrat Gazette - Arkansas Online

Rogers overtakes Bell in annual report on telecom complaints as wireless issues rise - CP24

European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types

Is SPDR MSCI EAFE StrategicFactors ETF (QEFA) a Strong ETF Right Now?

MPs call for House study of Rogers, Bell plans to raise wireless prices - The Globe and Mail

TSN, RDS, and Sportsnet land PWHL rights; Air Canada, Rogers named partners - Sportcal

Gaming Tycoon Solving His Most Complex Puzzle Yet: Climate Change - Forbes

Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform

FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results

Simile a ROG